This study unveils that ACSS2‐driven acetate metabolism fuels histone pan‐acetylation in pancreatic neuroendocrine tumors (PNETs), remodeling the epigenetic landscape. The gene discussed is ACSS2; the disease is pancreatic neuroendocrine tumor.